Business
Ultragenyx Pharmaceutical Inc. (RARE) Q4 2025 Earnings Call Transcript
Operator
Good afternoon, and welcome to the Ultragenyx Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions]
It is now my pleasure to turn the call to Joshua Higa, Vice President of Investor Relations.
Joshua Higa
Director of Investor Relations & Corporate Communications
Thank you. We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com.
Joining me on this call are Emil Kakkis, Chief Executive Officer and President; Howard Horn, Chief Financial Officer; Erik Harris, Chief Commercial Officer; and Eric Crombez, Chief Medical Officer.
I’d like to remind everyone that during today’s call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please refer to the risk factors discussed in our latest SEC filings.
I’ll now turn the call over to Emil.